Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...

Vanda Pharmaceuticals sees strong growth with Fanapt for bipolar I disorder, projects 2025 revenue up 6%-26%, and targets $1B by 2030.

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

Please view our affiliate disclosure. In the digital age, AI-powered presentation generators are revolutionizing the way we create and deliver presentations. These tools leverage artificial ...

Sun Pharmaceutical Industries reported a 15% rise in net profit for the December quarter, driven by strong global sales. The company's revenue reached Rs 13,675 crore. An interim dividend of Rs 10.5 ...

HYDERABAD/BENGALURU (Reuters) -Sun Pharmaceutical, India’s largest drugmaker by revenue, reported a bigger-than-expected quarterly profit on Friday, aided by strong sales in the domestic market. The ...

Shares of Sun Pharma Ltd., India's largest drugmaker gained as much as 1.3% after declining as much as 2% when it reported its December quarter results. The stock gained despite its US formulation ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

Swiss pharmaceutical giant Novartis on Friday reported better-than-expected sales in the fourth quarter ... "We actually have tremendous replacement power," he said, referring to drug makers ...

On Friday, when AbbVie reported its quarterly earnings, the pharma giant jacked up its 2027 projected sales of Humira follow-ons Skyrizi and Rinvoq to a combined $31 billion. It is a $4 billion ...